Literature DB >> 12517682

Different drug classes have variable effects on blood pressure depending on the time of day.

Trefor O Morgan1, Adrianne Anderson.   

Abstract

BACKGROUND: Blood pressure (BP) is controlled by a variety of systems, the activities of which vary throughout the day. As drugs are developed that selectively block these systems, the fall in BP may not be consistent over 24 h.
METHODS: A total of 24 patients (aged >65 years) with systolic BP (SBP; >150 mm Hg) that had not been treated entered a substudy of a larger study performed in 74 patients. In a double blind, crossover study with a balanced design, they received placebo, atenolol 50 mg, perindopril 8 mg, felodipine 10 mg, or hydrochlorothiazide 50 mg. The study periods were 2 months. Ambulatory BP monitoring was performed at the end of each period, and was divided into awake periods (9:00 AM to 10:00 PM), sleep periods (12:00 AM to 6:00 AM), and morning periods (6:00 AM to 9:00 AM). Medication was taken at 9:00 AM.
RESULTS: The four drug classes lowered 24-h mean SBP (P <.05), but the fall with atenolol was less than with the other drugs. The fall in awake BP with perindopril was less than with felodipine or hydrochlorothiazide. Atenolol caused no significant fall in sleep or morning SBP, and the falls with the other three drugs were significant and were greater than the fall with atenolol. The fall in sleep BP with perindopril was greater than with the other drug classes. The awake-sleep difference in SBP increased with perindopril, stayed the same with felodipine and hydrochlorothiazide, and was reduced by atenolol.
CONCLUSIONS: In this study, the response to the different drug classes differed. The response to drugs that work relatively nonspecifically (diuretics, calcium blockers) was relatively consistent over 24 h. The response to beta blockers and to angiotensin converting enzyme inhibitors reflected the activity of control systems. This finding supports the concept of multiple drug therapy that may need to be tailored to the time of day.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12517682     DOI: 10.1016/s0895-7061(02)03081-9

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  12 in total

Review 1.  Valsartan/hydrochlorothiazide: a review of its use in the management of hypertension.

Authors:  Antona J Wagstaff
Journal:  Drugs       Date:  2006       Impact factor: 9.546

2.  Diuretic drugs benefit patients with hypertension more with night-time dosing.

Authors:  Basil N Okeahialam; Esther N Ohihoin; Jayne Na Ajuluchukwu
Journal:  Ther Adv Drug Saf       Date:  2012-12

3.  Quantifying risk of adverse clinical events with one set of vital signs among primary care patients with hypertension.

Authors:  William M Tierney; Margaret Brunt; Joseph Kesterson; Xiao-Hua Zhou; Gil L'Italien; Pablo Lapuerta
Journal:  Ann Fam Med       Date:  2004 May-Jun       Impact factor: 5.166

4.  Beta-blockers, hypertension, and stroke outcomes.

Authors:  Magnus O Wijkman
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-03-09       Impact factor: 3.738

5.  Association Between the ACA Medicaid Expansions and Changes in Cardiovascular Risk Factors Among Low-Income Individuals.

Authors:  Hiroshi Gotanda; Gerald F Kominski; David Elashoff; Yusuke Tsugawa
Journal:  J Gen Intern Med       Date:  2021-01-22       Impact factor: 6.473

6.  The risk of cardiovascular events in primary care patients following an episode of severe hypertension.

Authors:  Edward Ewen; Zugui Zhang; Paul Kolm; Claudine Jurkovitz; Joseph Jackson; Dogan Fidan; William S Weintraub
Journal:  J Clin Hypertens (Greenwich)       Date:  2009-04       Impact factor: 3.738

Review 7.  EUROPA: has anything new been learned with angiotensin-converting enzyme inhibitors?

Authors:  Domenic A Sica
Journal:  J Clin Hypertens (Greenwich)       Date:  2004-02       Impact factor: 3.738

Review 8.  Systolic hypertension in the elderly: pushing the frontiers of therapy--a suggested new approach.

Authors:  Gordon S Stokes
Journal:  J Clin Hypertens (Greenwich)       Date:  2004-04       Impact factor: 3.738

9.  Comparative efficacy of two different beta-blockers on 24-hour blood pressure control.

Authors:  Pantelis Sarafidis; Zvezdana Bogojevic; Emad Basta; Emily Kirstner; George L Bakris
Journal:  J Clin Hypertens (Greenwich)       Date:  2008-02       Impact factor: 3.738

Review 10.  The dilemma of nocturnal blood pressure.

Authors:  Tan Xu; Yong-Qing Zhang; Xue-Rui Tan
Journal:  J Clin Hypertens (Greenwich)       Date:  2012-09-12       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.